Results 101 to 110 of about 4,088,174 (172)

Stereotactic body radiotherapy (SBRT) reirradiation for pelvic recurrence from colorectal cancer

open access: yes, 2015
Background and ObjectivesWhen surgery is not adequate or feasible, stereotactic body radiotherapy (SBRT) reirradiation has been used for recurrent cancers.
Nagle, Deborah   +9 more
core   +1 more source

Comment on “PSMA response evaluation in follow-up PSMA-PET/CT after stereotactic ablative body radiotherapy (SABR) for oligometastases in prostate cancer”

open access: yesClinical and Translational Radiation Oncology
The recently published study by Zang et al. offers valuable insight into PSMA-PET/CTbased response assessment in patients with oligometastatic prostate cancer (PCa) undergoing stereotactic ablative body radiotherapy (SABR), demonstrating an impressive 5 ...
Parth Aphale   +2 more
doaj   +1 more source

Improving timeliness of lung cancer care through a rapid assessment clinic

open access: yesInternal Medicine Journal, EarlyView.
Abstract Background Early diagnosis and treatment of lung cancer improve survival. Guidelines from Australia and worldwide stipulate timeframes of care from referral. The Rapid Lung Assessment Clinic (RLAC) was established to fast‐track the diagnostic and treatment pathway, with a subsequent quality improvement initiative based on the initial analysis ...
Shakti V. Dabholkar   +6 more
wiley   +1 more source

Exploring All Avenues for Radiotherapy in Oligorecurrent Prostate Cancer Disease Limited to Lymph Nodes: A Systematic Review of the Role of Stereotactic Body Radiotherapy [PDF]

open access: yes, 2017
Stereotactic body radiotherapy (SBRT) is emerging as a treatment option in patients affected by oligorecurrent prostate cancer disease limited to lymph nodes, a subgroup of patients who would otherwise be treated only with androgen deprivation therapy ...
Piet Ost   +13 more
core   +1 more source

Case Report: Abscopal effect in a patient with refractory metastatic hepatocellular carcinoma treated with stereotactic body radiotherapy and PD-1 inhibitor

open access: yesFrontiers in Immunology
There is currently no established standard treatment for patients with metastatic hepatocellular carcinoma after resistance to tyrosine kinase inhibitors.
Pei Shu   +5 more
doaj   +1 more source

Survival outcomes in dogs treated with vinorelbine‐based adjuvant treatment following surgical resection of grade II and III pulmonary carcinoma

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives Pulmonary carcinoma in dogs is commonly managed with surgical resection; however, the role of adjuvant chemotherapy for grade II and III carcinomas remains unclear. This retrospective multicentre study investigated the outcomes in dogs treated with vinorelbine‐based adjuvant treatment (as monotherapy or combined chemotherapy) following ...
N. Wong, L. Brockley, S. Rajan, J. Yu
wiley   +1 more source

Protocol for Scoping Review on Stereotactic Body Radiotherapy Boost in Cervical Cancer Treatment

open access: yes
This scoping review aims to objectively explore the effectiveness and safety of Stereotactic Body Radiotherapy Boost as a surrogate for brachytherapy in patients diagnosed with cervical ...
Ana Verena Silvany Sampaio de Miranda   +6 more
core   +1 more source

Case report: Stereotactic MR-guided adaptive radiotherapy for inoperable urothelial carcinoma at the renal pelvis

open access: yesFrontiers in Oncology
We report the case of an 87-year-old woman with upper tract urothelial carcinoma at the left renal pelvis. She received stereotactic body radiotherapy of 35 Gy in five fractions for palliative treatment of hematuria that was delivered by a 1.5-T magnetic
Wajana Thaweerat, Pittaya Dankulchai
doaj   +1 more source

A dose‐escalated radiation protocol of 10 × 4.0 Gy provides long‐term local control in canine apocrine gland anal sac adenocarcinoma

open access: yesJournal of Small Animal Practice, EarlyView.
Objectives To obtain insights for establishing radiation therapy strategies that provide long‐term locoregional benefits in canine apocrine gland anal sac adenocarcinoma, we evaluated whether a dose‐escalated protocol (10 × 4.0 Gy) could improve clinical outcomes, particularly long‐term locoregional control, while maintaining acceptable toxicity ...
M. Terauchi   +3 more
wiley   +1 more source

Stereotactic body radiotherapy takes on Lung Oligometastases: Latest breakthroughs

open access: yesPrecision Radiation Oncology
Lung oligometastases represent an intermediate state of cancer dissemination between localized and widespread metastases. Stereotactic body radiation therapy (SBRT) has emerged as an effective treatment option, with an efficacy comparable to that of ...
Xin Liu   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy